Copeptin and Long-Term Risk of Recurrent Vascular Events After Transient Ischemic Attack and Ischemic Stroke: Population-Based Study [Clinical Sciences]
Conclusions—
In patients with TIA and ischemic stroke, copeptin predicted recurrent vascular events and death, particularly after cardioembolic TIA/stroke. Further validation is required, in particular, in studies using more extensive cardiac evaluation.
Source: Stroke - Category: Neurology Authors: Greisenegger, S., Segal, H. C., Burgess, A. I., Poole, D. L., Mehta, Z., Rothwell, P. M. Tags: Acute Cerebral Infarction, Epidemiology Clinical Sciences Source Type: research
More News: Cardiology | Epidemiology | Heart | Heart Attack | Heart Failure | Ischemic Stroke | Neurology | Stroke | Study